Company: TAK
Filing Date: 2025-06-25
Form Type: 20-F
Source: 0001395064-25-000095
Chunk: 205

Company: TAKEDA PHARMACEUTICAL CO LTD
Filing Date: 2025-06-25
Form: 20-F
Item: Item 16C
Chunk 205
---
Item 16C. Principal Accountant Fees and Services

Audit and Non‑ Audit Fees

The following table sets forth the fees billed to us by our independent certified public accountant, KPMG AZSA LLC (including its Japanese and non-Japanese affiliates), in the fiscal years ended March 31, 2024 and 2025:

                              For the fiscal year ended                      
                              March 31,                                      
                              2024                                           
 ─────────────────────────────────────────────────────────────────────────────
                              (billions of yen)                              
  Audit fees (1)              ¥                              3.71      3.57  
  Audit‑related fees (2)                                     0.22      0.14  
  Other fees (3)                                             0.03      0.07  
  Total fees                  ¥                              3.97      3.78  

____________

Notes:

(1) Audit fees were related to the audit of our consolidated financial statements and other audit services provided in connection with statutory and regulatory filings or engagements.

(2) Audit‑related fees include fees related to other assurance and related services including limited assurance on certain sustainability information and agreed-upon procedures.

(3) Other fees include fees for other permissible services including readiness review for certain rule and regulations.

Pre‑ Approval Policies and Procedures

Pursuant to Rule 2-01(c)(7)(i) of Regulation S-X, we have adopted policies and procedures under which all services (including permissible non-audit services) for which we or our subsidiaries engage our independent certified public accountant, KPMG AZSA LLC, and its affiliates must be approved by our Audit and Supervisory Committee prior to entering into an engagement.

All audit services are subject to the pre-approval by the Audit and Supervisory Committee in principle, regardless of monetary value. Audit services include statutory or financial statement audits for us and our subsidiaries, services associated with the audit of internal control over financial reporting and services associated with the review of our semi-annual financial statements. On a yearly basis, our management, following a review by our Chief Financial Officer, presents the proposed audit services to our Audit and Supervisory Committee for approval, and proposes audit fees on an entity basis to the Audit and Supervisory Committee for its consent. Once such services and fees are approved or consented to, as applicable, any additional audit services must be separately presented to and approved by our Audit and Supervisory Committee.

Permissible non-audit services, which are limited to certain services permissible